基线灌注CT参数作为预测局限性透明细胞肾细胞癌长期预后的潜在生物标志物
本研究回顾性纳入2005年3月至2007年5月间接受灌注CT的127例患者,其中61例经病理证实为pT1N0M0或pT2N0M0透明细胞肾细胞癌,平均随访118.8个月。结果发现转移组基线肿瘤血流量显著高于无转移组,多因素Cox回归显示T分期、Fuhrmann分级和血流量与无进展生存期显著相关,基线血流量>230 ml/min/100 g时风险比达12.90。作者认为基线肿瘤血流量是预测局限性透明细胞肾细胞癌长期转移的潜在生物标志物。
要点
- 转移组基线肿瘤血流量为429.1 ml/min/100 g,显著高于无转移组的214.3 ml/min/100 g(p=0.011)。
- 多因素Cox回归中,T分期、Fuhrmann分级和血流量与无进展生存期显著相关,风险比分别为3.35、3.08和1.006。
- 血流量>230 ml/min/100 g与无进展生存期相关,风险比12.90。
核心结论
- 基线肿瘤血流量是预测局限性透明细胞肾细胞癌长期转移的潜在生物标志物,可能有助于筛选肾切除术后需要个体化监测策略的高危患者。
研究设计与样本
- 回顾性研究,自2005年3月至2007年5月共收集127例接受灌注CT的患者,其中61例经病理证实为pT1N0M0或pT2N0M0透明细胞肾细胞癌,平均随访时间118.8个月(±13.1个月,范围72-135个月)。
诊断标准与关键数值
- 转移组基线肿瘤血流量为429.1(233.8,570.1)ml/min/100 g,无转移组为214.3(153.3,376.5)ml/min/100 g,两组差异p=0.011。
- 多因素Cox回归中,T分期、Fuhrmann分级和血流量与无进展生存期显著相关,风险比分别为3.35、3.08和1.006。
- 另一模型中,血流量>230 ml/min/100 g与无进展生存期相关,风险比12.90,T分期和Fuhrmann分级风险比分别为4.73和3.69。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aimed to explore the relationship among baseline perfusion CT parameters, clinical, and pathological factors with post-nephrectomy long-term progression-free survival in localized clear cell renal cell carcinoma.
MATERIALS AND METHODS: This study retrospectively collected 127 patients from March 2005 to May 2007 who undertook perfusion CT. 61 patients were confirmed of pT1N0M0 or pT2N0M0 ccRCC. The mean follow-up time is 118.8 months (± 13.1 m, range 72-135 m). We compared clinical, pathological factors (gender, T stage, age, Fuhrmann grade, VEGF level, and MVD), and perfusion parameters before treatment [blood flow (BF), blood volume, mean transition time, and permeability surface-area product] between groups with post-nephrectomy metastasis and without metastasis. Association between covariates and progression-free survival (PFS) were analyzed using Cox proportional regression.
RESULTS: Among 61 patients, 11 developed distant metastasis (10 in the lung, one in the bone). BF in metastatic group [429.1 (233.8, 570.1) ml/min/100 g] was significantly higher than non-metastatic group [214.3 (153.3, 376.5) ml/min/100 g] (p = 0.011). Metastatic group also had more patients with higher Fuhrmann grade. Multi-covariant Cox regression demonstrated T staging, Fuhrmann grade, and BF were significantly associated with PFS [hazard ratio (HR) 3.35, 3.08, and 1.006]. In another model, BF > 230 ml/min/100 g was associated with PFS (HR 12.90), along with T staging and Fuhrmann grade (HR 4.73, 3.69).
CONCLUSION: Baseline tumor BF is a potential biomarker in prediction long-term metastasis of localized ccRCC and may help screening for higher risk localized ccRCC patients who need personalized surveillance strategy after nephrectomy.
引用
- Wang Y, Cui L, Zhang J, et al. Baseline perfusion CT parameters as potential biomarkers in predicting long-term prognosis of localized clear cell renal cell carcinoma. Abdom Radiol (NY). 2019. PMID: 31399787. doi:10.1007/s00261-019-02087-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。